1. Home
  2. SONN vs MGIH Comparison

SONN vs MGIH Comparison

Compare SONN & MGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SONN
  • MGIH
  • Stock Information
  • Founded
  • SONN N/A
  • MGIH 1978
  • Country
  • SONN United States
  • MGIH Hong Kong
  • Employees
  • SONN N/A
  • MGIH N/A
  • Industry
  • SONN Biotechnology: Pharmaceutical Preparations
  • MGIH Publishing
  • Sector
  • SONN Health Care
  • MGIH Consumer Discretionary
  • Exchange
  • SONN Nasdaq
  • MGIH Nasdaq
  • Market Cap
  • SONN 21.4M
  • MGIH 18.0M
  • IPO Year
  • SONN N/A
  • MGIH 2023
  • Fundamental
  • Price
  • SONN $5.90
  • MGIH $2.80
  • Analyst Decision
  • SONN Strong Buy
  • MGIH
  • Analyst Count
  • SONN 1
  • MGIH 0
  • Target Price
  • SONN $20.00
  • MGIH N/A
  • AVG Volume (30 Days)
  • SONN 825.4K
  • MGIH 3.9M
  • Earning Date
  • SONN 08-13-2025
  • MGIH 10-29-2025
  • Dividend Yield
  • SONN N/A
  • MGIH N/A
  • EPS Growth
  • SONN N/A
  • MGIH N/A
  • EPS
  • SONN N/A
  • MGIH N/A
  • Revenue
  • SONN $1,000,000.00
  • MGIH $28,866,993.00
  • Revenue This Year
  • SONN $5,376.22
  • MGIH N/A
  • Revenue Next Year
  • SONN N/A
  • MGIH N/A
  • P/E Ratio
  • SONN N/A
  • MGIH N/A
  • Revenue Growth
  • SONN 1689.52
  • MGIH N/A
  • 52 Week Low
  • SONN $1.08
  • MGIH $1.34
  • 52 Week High
  • SONN $19.30
  • MGIH $6.83
  • Technical
  • Relative Strength Index (RSI)
  • SONN 74.18
  • MGIH 67.01
  • Support Level
  • SONN $2.71
  • MGIH $1.83
  • Resistance Level
  • SONN $4.35
  • MGIH $4.84
  • Average True Range (ATR)
  • SONN 0.58
  • MGIH 0.62
  • MACD
  • SONN 0.22
  • MGIH 0.06
  • Stochastic Oscillator
  • SONN 80.96
  • MGIH 37.99

About SONN Sonnet BioTherapeutics Holdings Inc.

Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.

About MGIH Millennium Group International Holdings Limited

Millennium Group International Holdings Ltd is a paper-based packaging solutions supplier. It offers paper-based inner and outer packaging products which can be broadly categorized into packaging products, Packaging products supply chain management solutions and corrugated products.

Share on Social Networks: